Gsk Total Assets Growth & History (GSK)

Gsk's total assets was £61.12B for fiscal 2025.

View full Gsk company overview

Gsk annual total assets history

Gsk annual total assets

Fiscal yearPeriod endedTotal assetsChangeGrowth
20252025-12-31£61.12B£1.66B+2.78%
20242024-12-31£59.46B£458.0M+0.78%
20232023-12-31£59.01B−£1.14B−1.90%
20222022-12-31£60.15B−£18.96B−23.96%
20212021-12-31£79.10B−£1.33B−1.65%
20202020-12-31£80.43B£739.0M+0.93%
20192019-12-31£79.69B£21.63B+37.24%
20182018-12-31£58.07B£1.69B+2.99%
20172017-12-31£56.38B−£2.70B−4.57%
20162016-12-31£59.08B

Gsk total assets trends

Over the last five fiscal years, Gsk's total assets decreased from £80.43B to £61.12B, a change of −£19.31B. The latest reported quarter, Q2 2026, shows £61.74B.

About the metric

What total assets mean

Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.

Calculation and source

SEC-reported total assets

TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Gsk source filings ↗

Community posts

It’s quiet here.

No posts about GSK yet. Start the conversation.

Write the first post